vs

Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and SIFCO INDUSTRIES INC (SIF). Click either name above to swap in a different company.

IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $24.0M, roughly 2.0× SIFCO INDUSTRIES INC). SIFCO INDUSTRIES INC runs the higher net margin — 7.5% vs -4.8%, a 12.2% gap on every dollar of revenue. On growth, SIFCO INDUSTRIES INC posted the faster year-over-year revenue change (14.8% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $8.0M). Over the past eight quarters, SIFCO INDUSTRIES INC's revenue compounded faster (8.1% CAGR vs -20.2%).

Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.

SIFCO Industries, Inc. (SIFCO), is a global metal component manufacturer based in Cleveland, Ohio.

IRWD vs SIF — Head-to-Head

Bigger by revenue
IRWD
IRWD
2.0× larger
IRWD
$47.7M
$24.0M
SIF
Growing faster (revenue YoY)
SIF
SIF
+62.1% gap
SIF
14.8%
-47.3%
IRWD
Higher net margin
SIF
SIF
12.2% more per $
SIF
7.5%
-4.8%
IRWD
More free cash flow
IRWD
IRWD
$66.6M more FCF
IRWD
$74.6M
$8.0M
SIF
Faster 2-yr revenue CAGR
SIF
SIF
Annualised
SIF
8.1%
-20.2%
IRWD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
IRWD
IRWD
SIF
SIF
Revenue
$47.7M
$24.0M
Net Profit
$-2.3M
$1.8M
Gross Margin
21.6%
Operating Margin
14.3%
10.7%
Net Margin
-4.8%
7.5%
Revenue YoY
-47.3%
14.8%
Net Profit YoY
-200.9%
177.3%
EPS (diluted)
$0.01
$0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRWD
IRWD
SIF
SIF
Q4 25
$47.7M
$24.0M
Q3 25
$122.1M
$22.8M
Q2 25
$85.2M
$22.1M
Q1 25
$41.1M
$19.0M
Q4 24
$90.5M
$20.9M
Q3 24
$91.6M
$21.7M
Q2 24
$94.4M
$22.0M
Q1 24
$74.9M
$20.5M
Net Profit
IRWD
IRWD
SIF
SIF
Q4 25
$-2.3M
$1.8M
Q3 25
$40.1M
$-429.0K
Q2 25
$23.6M
$3.4M
Q1 25
$-37.4M
$-1.4M
Q4 24
$2.3M
$-2.3M
Q3 24
$3.6M
$-443.0K
Q2 24
$-860.0K
$72.0K
Q1 24
$-4.2M
$-1.6M
Gross Margin
IRWD
IRWD
SIF
SIF
Q4 25
21.6%
Q3 25
9.6%
Q2 25
26.7%
Q1 25
8.3%
Q4 24
4.4%
Q3 24
10.7%
Q2 24
12.3%
Q1 24
7.3%
Operating Margin
IRWD
IRWD
SIF
SIF
Q4 25
14.3%
10.7%
Q3 25
61.8%
-1.7%
Q2 25
53.2%
14.8%
Q1 25
-70.7%
-4.1%
Q4 24
34.8%
-9.2%
Q3 24
28.0%
-1.5%
Q2 24
26.5%
0.7%
Q1 24
14.7%
-6.5%
Net Margin
IRWD
IRWD
SIF
SIF
Q4 25
-4.8%
7.5%
Q3 25
32.8%
-1.9%
Q2 25
27.7%
15.4%
Q1 25
-90.9%
-7.3%
Q4 24
2.5%
-11.1%
Q3 24
4.0%
-2.0%
Q2 24
-0.9%
0.3%
Q1 24
-5.6%
-7.8%
EPS (diluted)
IRWD
IRWD
SIF
SIF
Q4 25
$0.01
$0.29
Q3 25
$0.23
$-0.07
Q2 25
$0.14
$0.56
Q1 25
$-0.23
$-0.23
Q4 24
$0.03
$-0.38
Q3 24
$0.02
$-0.07
Q2 24
$-0.01
$0.01
Q1 24
$-0.03
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRWD
IRWD
SIF
SIF
Cash + ST InvestmentsLiquidity on hand
$215.5M
$1.1M
Total DebtLower is stronger
$39.0K
Stockholders' EquityBook value
$-261.8M
$38.7M
Total Assets
$396.9M
$74.9M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRWD
IRWD
SIF
SIF
Q4 25
$215.5M
$1.1M
Q3 25
$140.4M
$491.0K
Q2 25
$92.9M
$2.0M
Q1 25
$108.5M
$1.9M
Q4 24
$88.6M
$3.1M
Q3 24
$88.2M
$1.7M
Q2 24
$105.5M
$3.4M
Q1 24
$121.5M
$2.5M
Total Debt
IRWD
IRWD
SIF
SIF
Q4 25
$39.0K
Q3 25
$199.5M
$51.0K
Q2 25
$199.3M
Q1 25
$199.2M
Q4 24
$199.0M
Q3 24
$198.8M
$0
Q2 24
$198.6M
$3.6M
Q1 24
$398.3M
$4.1M
Stockholders' Equity
IRWD
IRWD
SIF
SIF
Q4 25
$-261.8M
$38.7M
Q3 25
$-264.2M
$36.9M
Q2 25
$-308.2M
$35.8M
Q1 25
$-334.1M
$32.4M
Q4 24
$-301.3M
$33.7M
Q3 24
$-311.3M
$30.4M
Q2 24
$-321.7M
$29.8M
Q1 24
$-330.5M
$29.7M
Total Assets
IRWD
IRWD
SIF
SIF
Q4 25
$396.9M
$74.9M
Q3 25
$396.1M
$73.4M
Q2 25
$342.9M
$77.3M
Q1 25
$327.2M
$78.8M
Q4 24
$350.9M
$81.0M
Q3 24
$389.5M
$104.6M
Q2 24
$395.6M
$106.3M
Q1 24
$438.8M
$104.2M
Debt / Equity
IRWD
IRWD
SIF
SIF
Q4 25
0.00×
Q3 25
0.00×
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.12×
Q1 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRWD
IRWD
SIF
SIF
Operating Cash FlowLast quarter
$74.6M
$8.1M
Free Cash FlowOCF − Capex
$74.6M
$8.0M
FCF MarginFCF / Revenue
156.3%
33.3%
Capex IntensityCapex / Revenue
0.0%
0.4%
Cash ConversionOCF / Net Profit
4.51×
TTM Free Cash FlowTrailing 4 quarters
$127.0M
$11.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRWD
IRWD
SIF
SIF
Q4 25
$74.6M
$8.1M
Q3 25
$47.6M
$726.0K
Q2 25
$-15.1M
$371.0K
Q1 25
$20.0M
$2.8M
Q4 24
$15.2M
$-3.8M
Q3 24
$9.9M
$857.0K
Q2 24
$33.5M
$382.0K
Q1 24
$45.0M
$-3.2M
Free Cash Flow
IRWD
IRWD
SIF
SIF
Q4 25
$74.6M
$8.0M
Q3 25
$47.6M
$566.0K
Q2 25
$-15.1M
$310.0K
Q1 25
$19.9M
$2.7M
Q4 24
$-3.9M
Q3 24
$9.9M
$580.0K
Q2 24
$33.4M
$-175.0K
Q1 24
$44.9M
$-3.9M
FCF Margin
IRWD
IRWD
SIF
SIF
Q4 25
156.3%
33.3%
Q3 25
39.0%
2.5%
Q2 25
-17.7%
1.4%
Q1 25
48.4%
14.1%
Q4 24
-18.8%
Q3 24
10.8%
2.7%
Q2 24
35.4%
-0.8%
Q1 24
60.0%
-18.9%
Capex Intensity
IRWD
IRWD
SIF
SIF
Q4 25
0.0%
0.4%
Q3 25
0.0%
0.7%
Q2 25
0.0%
0.3%
Q1 25
0.1%
0.8%
Q4 24
0.0%
0.5%
Q3 24
0.0%
1.3%
Q2 24
0.1%
2.5%
Q1 24
0.1%
3.3%
Cash Conversion
IRWD
IRWD
SIF
SIF
Q4 25
4.51×
Q3 25
1.19×
Q2 25
-0.64×
0.11×
Q1 25
Q4 24
6.74×
Q3 24
2.71×
Q2 24
5.31×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRWD
IRWD

Segment breakdown not available.

SIF
SIF

Fixed Wing Aircraft Revenue$10.5M44%
Commercial Revenue$8.7M36%
Commercial Product And Other Revenue$2.8M12%
Commercial Space$1.1M5%
Other$840.0K4%

Related Comparisons